Studies have demonstrated that this agent is teratogenic when administered to animals. Dacarbazine therefore should not be administered to pregnant women or women who are suspected of being pregnant.
Since the safe use in nursing mothers has not been established, breast feeding should be avoided during dacarbazine therapy.